40
Participants
Start Date
November 30, 2012
Primary Completion Date
December 31, 2013
Study Completion Date
August 31, 2014
Sofosbuvir
Sofosbuvir 400 mg tablet administered orally once daily
RBV
Ribavirin (RBV) 200-mg tablet(s) administered orally in a divided daily dose starting at 400 mg, subsequently adjusted (range: 200 to 1200 mg in a divided daily dose) based upon a number of factors including hemoglobin value, creatinine clearance, and weight.
New York
New York
San Francisco
Indianapolis
Kansas City
Boston
Ann Arbor
Rochester
Villejuif
Hanover
Grafton
Barcelona
Lead Sponsor
Gilead Sciences
INDUSTRY